
- Oncology NEWS International Vol 8 No 7
- Volume 8
- Issue 7
Ultraviolet Light Slated for Review as Carcinogen
RESEARCH TRIANGLE PARK, NC-The National Toxicology Program (NTP) plans to review the three wavelength groups of ultraviolet light-UVA, UVB, and UVC-for possible listing in the federal government’s Tenth Annual Report on Carcinogens. The three wavelengths occur in varying amounts in sunlight and in some forms of artificial light, such as that used in sun lamps and tanning beds.
RESEARCH TRIANGLE PARK, NCThe National Toxicology Program (NTP) plans to review the three wavelength groups of ultraviolet lightUVA, UVB, and UVCfor possible listing in the federal governments Tenth Annual Report on Carcinogens. The three wavelengths occur in varying amounts in sunlight and in some forms of artificial light, such as that used in sun lamps and tanning beds.
Multilayered reviews are done to determine if a suspected carcinogen should be designated as a known human carcinogen or as reasonably anticipated to be a human carcinogen. The first review is done by scientists at the National Institute of Environmental Health Sciences and a second by scientists from a number of federal agencies. Finally, a panel of outside experts examines the data in a public hearing.
Among other substances being considered for listing:
The fire retardants 2,2-bis-bromo-methylpropanediol and 2,3-dibromo-1-propanol.
Vinyl bromide, which is used in making flame-retardant synthetic fibers.
Vinyl fluoride, used in producing plastics.
Two classes of dyesthe dimeth-oxybenzidines and dimethylbenzidinesused in textiles, leather, plastics, paper, and rubber.
Styrene-7,8-oxide, used in preparing fragrances and in some epoxy resins.
IQ, a compound found in cooked meat and fish.
In addition, beryllium and beryllium compounds, currently on the reasonably anticipated list, will be reviewed for possible upgrading to known human carcinogens.
Articles in this issue
over 26 years ago
Nasal Angiogenesis Inhibitor May Stop Kaposi’s Sarcomaover 26 years ago
Surgeon’s Perspective on Neoadjuvant Chemo for Breast Cancerover 26 years ago
STAR Breast Cancer Prevention Trial Begins Enrollmentover 26 years ago
Studies Suggest New Approaches in Hereditary Ovarian Cancerover 26 years ago
Lycopene Beneficial in Prostate Cancerover 26 years ago
Komen Launches REMEMBERover 26 years ago
Advice and Support for Daughters of Breast Cancer Patientsover 26 years ago
Fetus May Be Harmed by Second-Hand Smokeover 26 years ago
Genes Linked to Smoking Affinity, Smoking-Induced Lung Cancerover 26 years ago
NCI Funding Complementary/Alternative Medicine TrialsNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.